Adaptive Biotechnologies ADPT Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Adaptive Biotechnologies in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Adaptive Biotechnologies's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Adaptive Biotechnologies's total current liabilities?
- Adaptive Biotechnologies (ADPT) reported total current liabilities of $87.01M in Q1 2026.
- How has Adaptive Biotechnologies's total current liabilities changed year-over-year?
- Adaptive Biotechnologies's total current liabilities decreased by 0.9% year-over-year, from $87.81M to $87.01M.
- What is the long-term trend for Adaptive Biotechnologies's total current liabilities?
- Over 5 years (2020 to 2025), Adaptive Biotechnologies's total current liabilities has grown at a -3.1% compound annual growth rate (CAGR), from $105.2M to $89.92M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.